Mac McMillan Appointed CEO of CynergisTek

Mac McMillan Appointed CEO of CynergisTek McMillan to Drive Growth in Security and Security Remediation Services for the Healthcare Industry                                                Austin, TX, October 4, 2017 – CynergisTek, Inc. (NYSE AMERICAN:CTEK), a leader in healthcare cybersecurity and information management, today announced that its Board of Directors has appointed Mac McMillan as CEO, effective immediately. McMillan... read more

AEHIS, MDISS to Collaborate on New Medical Device Cybersecurity Projects

ANN ARBOR, MI, Oct. 5, 2017 – The Association for Executives in Healthcare Information Security (AEHIS) and the Medical Device Innovation, Safety and Security Consortium (MDISS) announced today that they will work collaboratively on activities designed to help their members identify, mitigate and prevent cybersecurity threats to medical devices. Their joint activities will focus on four areas of collaboration: education, best... read more

CynergisTek Appoints New Executive Vice President of Strategic Innovation

CynergisTek Appoints New Executive Vice President of Strategic Innovation Seasoned Healthcare Security Executive David Finn to Drive Strategic Direction of Top-Ranked Firm Austin, TX, October 2, 2017 — CynergisTek, (NYSE AMERICAN: CTEK), a leader in healthcare cybersecurity and information management, today announced that it has appointed David Finn as its first Executive Vice President of Strategic... read more

CynergisTek Executives Selected to Speak at Several Leading Healthcare Conferences

  CynergisTek Executives Selected to Speak at Several Leading Healthcare Conferences Company Thought Leaders to Discuss Top Issues and Trends in Healthcare Security, Privacy and Compliance at Events Across U.S. Austin, TX, September 19, 2017 — CynergisTek, (NYSE AMERICAN: CTEK), a leader in healthcare cybersecurity and information management, today announced that members of its executive team... read more

Three Healthcare Systems Choose FUJIFILM to Enhance Diagnostic Imaging Capabilities

THREE HEALTHCARE SYSTEMS CHOOSE FUJIFILM TO ENHANCE DIAGNOSTIC IMAGING CAPABILITIES   Stamford, CT, September 18, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging solutions with a comprehensive portfolio of digital radiography (DR) and mammography solutions, today announced that it has closed new contracts to enhance diagnostic imaging capabilities for existing customers... read more

Payment Security and Compliance: A Primer for Healthcare Revenue Cycle Decision Makers

Most hospitals are simply noncompliant with credit card data protection regulations. And if they are in compliance, the degree of compliance typically is unnecessarily high.   Healthcare revenue cycle leaders are acutely aware of the need to facilitate patient pay, particularly for the growing number of patients enrolled in high-deductible health plans (HDHPs). Although they... read more

Synapse VNA Version 6.4 Announces QIDO-RS and WADO-RS Support

September 6, 2017 - FUJIFILM Medical Systems U.S.A., Inc. introduces support for DICOM web services including QIDO-RS and WADO-RS in its Synapse® Vendor Neutral Archive (VNA) system with the launch of the latest version 6.4. Synapse VNA® is an enterprise-wide medical information and image management solution that serves as a vendor-neutral, scalable, and organizationally aware storage and distribution system for DICOM and non-DICOM objects.

Fujifilm Secures DIN-PACS IV Contract From US Department of Defense

August 23, 2017 - FUJIFILM Medical Systems USA today announced that it has earned a new 10-year contract with a maximum value of $768 million as part of the Digital Imaging Network-PACS IV project from the US Department of Defense and the US Department of Veterans Affairs.

FUJIFILM Launches Synapse PACS Version 5

August 3, 2017 - FUJIFILM Medical Systems U.S.A. announced the release of its Synapse PACS version 5 in the United States. Featuring the latest server-side rendering architecture, Synapse 5 is one component of Fujifilm’s comprehensive enterprise imaging portfolio which includes Synapse VNA, Enterprise Viewer, Cardiovascular, 3D, RIS and cloud services.

MHA Ventures Endorses Clearwater Compliance for Its Cybersecurity Preparedness Solution

August 2, 2017 - Clearwater Compliance today announced it will be the recommended cybersecurity provider of MHA Ventures’ Endorsed Services Program. Clearwater was awarded the preferred provider status by MHA Ventures. The new endorsement will offer education, solutions and services to the hospital members of MHA throughout Montana which includes 48 critical access hospitals, thirteen prospective payment system organizations, nine long-term care facilities, eight home health and hospice agencies, six governmental organizations, and one treatment facility.

CynergisTek Reports Double Digit Client Base Growth in First Half of 2017

July 27, 2017 - CynergisTek today announced it experienced unprecedented growth in the first half of 2017, with double digit net new client wins and expanded contracts. CynergisTek also expanded its service offerings over the past two quarters, with three new offerings unveiled, including Strategic & Remediation Services, HIPAA Research Program Assessment and Compliance Program Effectiveness Assessment services, in an effort to meet the increasing need for programs to support healthcare security, privacy and compliance.

The Most Wired Survey Shows That Growing Demand of Technologies Paves the Way for Transformation in Healthcare Delivery and Charts Course for Heightened Cybersecurity in Nation’s Hospitals

July 19, 2017 - The American Hospital Association’s 19th annual HealthCare’s Most Wired® benchmarking study and survey, sponsored by Clearwater Compliance, shows how technology and digital health tools play a crucial role across the healthcare and hospital industry with a major impact on driving patient engagement and improving diagnosis, safety, access to care, treatment, and communications.

CynergisTek Announces Three-Year, $750K Privacy Monitoring Deal

July 13, 2017 - CynergisTek today announced that a large, integrated health system located in the Midwest has selected its Managed Privacy Monitoring Service (MPMS). Under the terms of the three-year, $750K contract, CynergisTek's highly-trained IT privacy and security specialists will help implement, evaluate and optimize the organization's data privacy program.

Clearwater Compliance Joins National Institute of Standards and Technology’s National Cybersecurity Excellence Partnership

July 11, 2017 - Clearwater Compliance is pleased to announce it is the newest member of the National Institute of Standards and Technology’s (NIST) National Cybersecurity Excellence Partnership (NCEP) at NIST’s National Cybersecurity Center of Excellence (NCCoE). Clearwater joins 28 cybersecurity market leaders as part of the public-private industry collaboration that is focused on providing real-world, standards-based cybersecurity capabilities that address business needs. As an NCCoE NCEP member, Clearwater has pledged its award-winning cyber risk management software, methodology and expertise.

CynergisTek Announces Over $2 Million Professional Services Engagement with Nationally Recognized Health System

July 6, 2017 - CynergisTek today announced that it has closed three deals, equating to over $2 million, to provide a large health system with specialized security implementation and remediation services. CynergisTek's highly-trained IT security experts will support the health system in the areas of biomedical, web application, network security and payment card consulting over the next year.

CynergisTek Introduces HIPAA Research Program Assessment for Healthcare Organizations

June 6, 2017 - CynergisTek today announced the availability of its HIPAA Research Program Assessment. The new service provides healthcare organizations with a comprehensive, independent evaluation of its research policies, procedures and practices in accordance with the HIPAA Privacy and Security Rules, enforced by the Office for Civil Rights (OCR), as well as guidelines from the Food and Drug Administration and the Office of Human Research Protection.